83642-28-8 Usage
Explanation
The compound consists of 13 carbon atoms, 11 hydrogen atoms, 1 bromine atom, 3 oxygen atoms, and 1 sulfur atom in a single molecule.
2. Derivative of benzene
Explanation
1-bromo-4-(4-methylsulfonylphenoxy)benzene is derived from the basic benzene structure, with modifications at specific positions.
3. Bromine atom at the 1 position
Explanation
The bromine atom is attached to the benzene ring at the first carbon atom position (1).
4. 4-(4-methylsulfonylphenoxy) group at the 4 position
Explanation
A 4-(4-methylsulfonylphenoxy) group is attached to the benzene ring at the fourth carbon atom position (4).
5. Common use as an intermediate
Explanation
1-bromo-4-(4-methylsulfonylphenoxy)benzene is frequently used as a starting material or intermediate in the synthesis of various pharmaceuticals, agrochemicals, dyes, and pigments.
6. Building block in organic synthesis
Explanation
The compound serves as a fundamental building block in the creation of more complex organic molecules, contributing to the development of new compounds and materials.
7. Reagent in chemical research
Explanation
1-bromo-4-(4-methylsulfonylphenoxy)benzene is used as a reagent to facilitate various chemical reactions and processes in research settings.
8. Versatile and valuable compound
Explanation
The chemical structure of 1-bromo-4-(4-methylsulfonylphenoxy)benzene makes it a useful and important compound in a wide range of chemical and industrial applications.
Check Digit Verification of cas no
The CAS Registry Mumber 83642-28-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,3,6,4 and 2 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 83642-28:
(7*8)+(6*3)+(5*6)+(4*4)+(3*2)+(2*2)+(1*8)=138
138 % 10 = 8
So 83642-28-8 is a valid CAS Registry Number.
InChI:InChI=1/C13H11BrO3S/c1-18(15,16)13-8-6-12(7-9-13)17-11-4-2-10(14)3-5-11/h2-9H,1H3
83642-28-8Relevant academic research and scientific papers
Dihydropyrimidine compound and uses of dihydropyrimidine compound in drugs
-
Paragraph 1203; 1207; 1208; 1209, (2019/01/16)
The present invention relates to a dihydropyrimidine compound and uses of the dihydropyrimidine compound as drugs, particularly as drugs for treatment and prevention of hepatitis B, particularly to acompound represented by a general formula (I) or (Ia) or an enantiomer, a diastereomer, a tautomer, a hydrate, a solvate or a pharmaceutically acceptable salt thereof, wherein each variable is definedin the specification. The invention further relates to uses of the compound represented by a general formula (I) or (Ia) or the enantiomer, the diastereomer, the tautomer, the hydrate, the solvate orthe pharmaceutically acceptable salt thereof as drugs, especially as drugs for treatment and prevention of hepatitis B. The formulas (I) and (Ia) are defined in the specification.
DIHYDROPYRIMIDINE COMPOUNDS AND USES THEREOF IN MEDICINE
-
Paragraph 00448, (2019/01/17)
Provided herein are a dihydropyrimidine compound and a pharmaceutical application thereof, especially the application used for treating and preventing HBV diseases. Specifically, provided herein is a compound having Formula (I) or (Ia), or an enantiomer, a diastereoisomer, a tautomer, a hydrate, a solvate, or a pharmaceutically acceptable salt thereof, wherein the variables of the formulas are as defined in the specification. Also provided herein is use of the compound having Formula (I) or (Ia), or an enantiomer, a diastereoisomer, a tautomer, a hydrate, a solvate, or a pharmaceutically acceptable salt thereof as a medicine, especially for treating and preventing HBV diseases.
